Public Profile

Celgene Corporation

Celgene Corporation, a prominent biopharmaceutical company headquartered in the United States, has established itself as a leader in the development of innovative therapies for cancer and inflammatory diseases. Founded in 1986, Celgene has achieved significant milestones, including the successful launch of groundbreaking treatments that have transformed patient care. Operating primarily in North America and Europe, Celgene focuses on areas such as oncology, immunology, and haematology. Its core products, including Revlimid and Pomalyst, are renowned for their unique mechanisms of action and efficacy in treating complex conditions. With a strong market position, Celgene has garnered recognition for its commitment to research and development, making substantial contributions to the biopharmaceutical landscape.

DitchCarbon Score

How does Celgene Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

48

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Celgene Corporation's score of 48 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Celgene Corporation's reported carbon emissions

Celgene Corporation, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that Celgene may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the broader context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon footprints. However, without specific information on Celgene's emissions or commitments, it is challenging to assess their current climate impact or future goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Celgene Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Celgene Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Celgene Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Luye Pharma

CN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Novartis

CH
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Amgen

US
Chemicals nec
Updated 3 days ago

Merck And Co

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

United Therapeutics

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Eli Lilly and Company

GB
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers